Search research articles
Contact Us
Filters
Showing results (61-70 of 91) with videos related to
Page
of 10
Sort By:
JTO Clinical and Research Reports
|
September 30, 2021
Development and Validation of a Simplified Prognostic Score in SCLC
Elodie Negre, Amandine Coffy, Alexandra Langlais, et al.
Interactive Cardiovascular and Thoracic Surgery
|
March 14, 2015
A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective
Fabrice Barlesi, Christos Chouaid, Jacky Crequit, et al.
Plos One
|
August 21, 2019
An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer
Jean-Louis Pujol, Amandine Coffy, Andrea Camerini, et al.
Scientific Reports
|
October 4, 2017
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches
Julie A Vendrell, Sylvie Taviaux, Benoît Béganton, et al.
Clinical Lung Cancer
|
May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
Corey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2011
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer
Jean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, et al.
Future Oncology (London, England)
|
March 2, 2021
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
Pilar Garrido, Jean-Louis Pujol, Edward S Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study
Cesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Current Medical Research and Opinion
|
February 10, 2018
Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Gary Middleton, Cesare Gridelli, Filippo De Marinis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2012
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Cesare Gridelli, Filippo de Marinis, Jean-Louis Pujol, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 91) with videos related to
Sort By:
Page
of 10
JTO Clinical and Research Reports
|
September 30, 2021
Development and Validation of a Simplified Prognostic Score in SCLC
Elodie Negre, Amandine Coffy, Alexandra Langlais, et al.
Interactive Cardiovascular and Thoracic Surgery
|
March 14, 2015
A randomized trial comparing adjuvant chemotherapy with gemcitabine plus cisplatin with docetaxel plus cisplatin in patients with completely resected non-small-cell lung cancer with quality of life as the primary objective
Fabrice Barlesi, Christos Chouaid, Jacky Crequit, et al.
Plos One
|
August 21, 2019
An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer
Jean-Louis Pujol, Amandine Coffy, Andrea Camerini, et al.
Scientific Reports
|
October 4, 2017
Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches
Julie A Vendrell, Sylvie Taviaux, Benoît Béganton, et al.
Clinical Lung Cancer
|
May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
Corey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2011
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer
Jean-Charles Soria, Zsuzsanna Márk, Petr Zatloukal, et al.
Future Oncology (London, England)
|
March 2, 2021
Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design
Pilar Garrido, Jean-Louis Pujol, Edward S Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 14, 2014
Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study
Cesare Gridelli, Filippo de Marinis, Michael Thomas, et al.
Current Medical Research and Opinion
|
February 10, 2018
Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Gary Middleton, Cesare Gridelli, Filippo De Marinis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 13, 2012
Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer
Cesare Gridelli, Filippo de Marinis, Jean-Louis Pujol, et al.
Page
of 10